382 related articles for article (PubMed ID: 32727695)
1. [Venous thrombo-embolism during immune-mediated thrombotic thrombocytopenic purpura is prevalent in patients with a prolonged treatment with therapeutic plasma exchange].
Benhamou Y; Sauvètre G; Grangé S; Veyradier A; Coppo P
Rev Med Interne; 2020 Dec; 41(12):809-813. PubMed ID: 32727695
[TBL] [Abstract][Full Text] [Related]
2. Describing the point prevalence and characteristics of venous thromboembolism in patients with thrombotic thrombocytopenic purpura.
Tse B; Lim G; Sholzberg M; Pavenski K
J Thromb Haemost; 2020 Nov; 18(11):2870-2877. PubMed ID: 33448602
[TBL] [Abstract][Full Text] [Related]
3. [Management of thrombotic thrombocytopenic purpura in two French centers: A series of 27 patients].
Deroux A; Sirodot M; Daguindau N; Barro C; Coppo P; Bouillet L
Rev Med Interne; 2016 Jan; 37(1):13-8. PubMed ID: 26065327
[TBL] [Abstract][Full Text] [Related]
4. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
Som S; Deford CC; Kaiser ML; Terrell DR; Kremer Hovinga JA; Lämmle B; George JN; Vesely SK
Transfusion; 2012 Dec; 52(12):2525-32; quiz 2524. PubMed ID: 22501034
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience.
McGuckin S; Westwood JP; Webster H; Collier D; Leverett D; Scully M
Vox Sang; 2014 Feb; 106(2):161-6. PubMed ID: 24117855
[TBL] [Abstract][Full Text] [Related]
6. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
[TBL] [Abstract][Full Text] [Related]
7. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura.
Yarranton H; Cohen H; Pavord SR; Benjamin S; Hagger D; Machin SJ
Br J Haematol; 2003 Jun; 121(5):778-85. PubMed ID: 12780794
[TBL] [Abstract][Full Text] [Related]
9. Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.
Garraud O; Malot S; Herbrecht R; Ojeda-Uribe M; Lin JS; Veyradier A; Payrat JM; Liu K; Corash L; Coppo P
Transfus Apher Sci; 2019 Dec; 58(6):102665. PubMed ID: 31740165
[TBL] [Abstract][Full Text] [Related]
10. Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience.
Tse B; Buchholz M; Pavenski K
Platelets; 2023 Dec; 34(1):2157807. PubMed ID: 36636834
[TBL] [Abstract][Full Text] [Related]
11. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT).
Gómez-Seguí I; Francés Aracil E; Mingot-Castellano ME; Vara Pampliega M; Goterris Viciedo R; García Candel F; Pascual Izquierdo C; Del Río Garma J; Guerra Domínguez L; Vicuña Andrés I; Garcia-Arroba Peinado J; Zalba Marcos S; Vidan Estévez JM; González Arias E; Campuzano Saavedra V; García Gala JM; Ortega Sanchez S; Martínez Nieto J; Pardo Gambarte L; Solé Rodríguez M; Fernández-Docampo M; Avila Idrovo LF; Hernández L; Cid J; de la Rubia Comos J;
Br J Haematol; 2023 Dec; 203(5):860-871. PubMed ID: 37723363
[TBL] [Abstract][Full Text] [Related]
12. Deaths and complications associated with the management of acute immune thrombotic thrombocytopenic purpura.
Colling M; Sun L; Upadhyay V; Ryu J; Li A; Uhl L; Kaufman RM; Stowell CP; Dzik WH; Makar RS; Bendapudi PK
Transfusion; 2020 Apr; 60(4):841-846. PubMed ID: 32080877
[TBL] [Abstract][Full Text] [Related]
13. Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP).
Chen M; Shortt J
Transfus Med Rev; 2022 Oct; 36(4):204-214. PubMed ID: 36396570
[TBL] [Abstract][Full Text] [Related]
14. Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura.
Picod A; Coppo P
Expert Rev Hematol; 2019 Jun; 12(6):461-471. PubMed ID: 31092093
[No Abstract] [Full Text] [Related]
15. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry.
Blombery P; Kivivali L; Pepperell D; McQuilten Z; Engelbrecht S; Polizzotto MN; Phillips LE; Wood E; Cohney S;
Intern Med J; 2016 Jan; 46(1):71-9. PubMed ID: 26477687
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
[TBL] [Abstract][Full Text] [Related]
18. Management of Thrombotic Microangiopathic Hemolytic Anemias with Therapeutic Plasma Exchange: When It Works and When It Does Not.
Mehmood T; Taylor M; Winters JL
Hematol Oncol Clin North Am; 2016 Jun; 30(3):679-94. PubMed ID: 27113004
[TBL] [Abstract][Full Text] [Related]
19. Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.
Mancini I; Agosti P; Boscarino M; Ferrari B; Artoni A; Palla R; Spreafico M; Crovetti G; Volpato E; Rossini S; Novelli C; Gattillo S; Barcella L; Salmoiraghi M; Falanga A; Peyvandi F;
Orphanet J Rare Dis; 2022 Jun; 17(1):246. PubMed ID: 35739601
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
